NPM1 mutations may be associated with adverse outcome in the setting of myeloid neoplasms with complex karyotype. Ramia de Cap M, Wu LP, Pihan GA, Narayanan D, et al. Leuk Res 2022;123:106965.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ramia de Cap M, Wu LP, Pihan GA, Narayanan D, et al. NPM1 mutations may be associated with adverse outcome in the setting of myeloid neoplasms with complex karyotype. Leuk Res 2022;123:106965.
PMID: 36332291